Related Experiment Video

Updated: Aug 11, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

Postantibiotic effect of DX-619 against 16 gram-positive organisms

G A Pankuch1, P C Appelbaum

  • 1Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA.

Antimicrobial Agents and Chemotherapy
|August 30, 2005
PubMed

Insights

The novel antibiotic DX-619 exhibits significant postantibiotic effects (PAEs) and postantibiotic sub-minimum inhibitory concentration effects (PA-SMEs) against various Gram-positive bacteria, including Streptococcus pneumoniae, Staphylococcus, and Enterococcus species.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Antibiotic resistance is a growing global health threat, necessitating the development of new antimicrobial agents.
  • Understanding the pharmacodynamic properties of novel antibiotics, such as postantibiotic effects, is crucial for optimizing their therapeutic use.
  • DX-619 is an investigational antibiotic with potential activity against Gram-positive pathogens.

Purpose of the Study:

  • To determine the in vitro postantibiotic effects (PAEs), postantibiotic sub-MIC effects (PA-SMEs), and sub-MIC effects (SMEs) of DX-619.
  • To evaluate the duration of these effects against a panel of 16 Gram-positive organisms.
  • To characterize the activity of DX-619 in the post-exposure period.

Main Methods:

  • In vitro susceptibility testing was performed to determine the minimum inhibitory concentration (MIC) of DX-619 for each organism.
  • Bacterial cultures were exposed to DX-619 at concentrations of 4x MIC, 1x MIC, and 0.4x MIC.
  • Colony counts were assessed over time after removal of the antibiotic to determine PAE, PA-SME, and SME durations.

Main Results:

  • DX-619 demonstrated notable PAEs against *Streptococcus pneumoniae* (1.7–5.0 h), *Staphylococcus* (0.7–1.8 h), and *Enterococcus* (1.2–6.5 h) species.
  • The PA-SME durations at 0.4x MIC were substantial, ranging from 5.2 to >8.6 h for pneumococci, 2.1 to 8.3 h for staphylococci, and 4.9 to >10.0 h for enterococci.
  • These findings indicate a prolonged suppressive effect of DX-619 on bacterial regrowth after antibiotic exposure.

Conclusions:

  • DX-619 possesses significant in vitro postantibiotic effects against a range of clinically relevant Gram-positive bacteria.
  • The extended PAE and PA-SME of DX-619 suggest potential for less frequent dosing regimens, enhancing patient compliance and therapeutic efficacy.
  • Further clinical investigation is warranted to confirm the pharmacodynamic advantages of DX-619 in treating Gram-positive infections.

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...